These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9459168)

  • 1. Detection of DNA adducts by 32P postlabeling following chronic exposure of rats to snuff.
    Smith RA; Lawson T; Johansson SL
    Cancer Lett; 1997 Dec; 121(1):11-7. PubMed ID: 9459168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 32P-postlabeling and HPLC separation of DNA adducts formed by diesel exhaust extracts in vitro and in mouse skin and lung after topical treatment.
    Savela K; King L; Gallagher J; Lewtas J
    Carcinogenesis; 1995 Sep; 16(9):2083-9. PubMed ID: 7554058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
    Shibutani S; Kim SY; Suzuki N
    Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN; Weber WW
    Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA adduct formation after oral administration of 2-nitrofluorene and N-acetyl-2-aminofluorene, analyzed by 32P-TLC and 32P-HPLC.
    Möller L; Zeisig M
    Carcinogenesis; 1993 Jan; 14(1):53-9. PubMed ID: 8425271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of DNA binding in the rat nasal mucosa and other tissues of the nasal toxicants roflumilast, a phosphodiesterase 4 inhibitor, and a metabolite, 4-amino-3,5-dichloropyridine, in contrast to the nasal carcinogen 2,6-dimethylaniline.
    Jeffrey AM; Luo FQ; Amin S; Krzeminski J; Zech K; Williams GM
    Drug Chem Toxicol; 2002 Feb; 25(1):93-107. PubMed ID: 11850974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV
    IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity of coke-oven and urban air particulate matter in in vitro acellular assays coupled with 32P-postlabeling and HPLC analysis of DNA adducts.
    Binková B; Lenícek J; Benes I; Vidová P; Gajdos O; Fried M; Srám RJ
    Mutat Res; 1998 May; 414(1-3):77-94. PubMed ID: 9630530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC enrichment of hydrophobic DNA--carcinogen adducts for enhanced sensitivity of 32P-postlabeling analysis.
    Dunn BP; San RH
    Carcinogenesis; 1988 Jun; 9(6):1055-60. PubMed ID: 3286027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of an HPLC method for analyses of 32P-postlabeled DNA adducts.
    Möller L; Zeisig M; Vodicka P
    Carcinogenesis; 1993 Jul; 14(7):1343-8. PubMed ID: 8330347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P-postlabelling method for the detection of 7-alkylguanine adducts formed by the reaction of different 1,2-alkyl epoxides with DNA.
    Kumar R; Staffas J; Försti A; Hemminki K
    Carcinogenesis; 1995 Mar; 16(3):483-9. PubMed ID: 7697802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of TLC- and HPLC-32P-postlabelling assay for cisplatin-DNA adducts.
    Försti A; Staffas J; Hemminki K
    Carcinogenesis; 1994 Dec; 15(12):2829-34. PubMed ID: 8001242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
    Reddy MV; Irvin TR; Randerath K
    Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and persistence of benzo[a]pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformation.
    Suh M; Ariese F; Small GJ; Jankowiak R; Hewer A; Phillips DH
    Carcinogenesis; 1995 Oct; 16(10):2561-9. PubMed ID: 7586167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine.
    Otteneder M; Eder E; Lutz WK
    Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4-aminobiphenyl following nuclease P1 enrichment and 32P-postlabeling analysis.
    Hatcher JF; Swaminathan S
    Carcinogenesis; 1995 Feb; 16(2):295-301. PubMed ID: 7859361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and identification of benzo[a]pyrene-DNA adducts by [35S]phosphorothioate labeling and HPLC.
    Lau HH; Baird WM
    Carcinogenesis; 1991 May; 12(5):885-93. PubMed ID: 2029754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 32P-postlabeling analysis of DNA adducts from non-alternant PAH using thin-layer and high performance liquid chromatography.
    Weyand EH; Rice JE; LaVoie EJ
    Cancer Lett; 1987 Nov; 37(3):257-66. PubMed ID: 3677058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of two major ethylated deoxyguanosine adducts by high performance liquid chromatography, electrospray mass spectrometry, and 32P-postlabeling. Development of an approach for detection of phosphotriesters.
    Singh R; Sweetman GM; Farmer PB; Shuker DE; Rich KJ
    Chem Res Toxicol; 1997 Jan; 10(1):70-7. PubMed ID: 9074805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.